SRP4639

BMP-13 human

recombinant, expressed in E. coli, ≥95% (SDS-PAGE)

• Synonim(y): CDMP-2, Cartilage-Derived Morphogenetic Protein-2, GDF-6, bone morphogenetic protein 13
• Kod UNSPSC: 12352202
• NACRES: NA.32

Właściwości

• pochodzenie biologiczne: human
• rekombinowane: expressed in E. coli
• Próba: ≥95% (SDS-PAGE)
• Postać: lyophilized
• siła działania: 0.5-4 μg/mL ED₅₀ (determined by its ability to induce alkaline phosphatase production by ATDC-5 chondrogenic cells.)
• masa cząsteczkowa: ~27 kDa
• opakowanie: pkg of 50 μg
• warunki przechowywania: avoid repeated freeze/thaw cycles
• zanieczyszczenia: endotoxin, tested
• numer dostępu NCBI: Q6KF10
• Warunki transportu: wet ice
• temp. przechowywania: −20°C
• informacje o genach: human ... GDF6(392255)

Opis

Opis ogólny

BMPs (bone morphogenetic proteins) belong to the TGF-β superfamily of structurally related signaling proteins. These ligands mediate numerous physiological processes. BMPs initiate, promote and maintain cartilage and bone development, growth, remodeling and repair, in both prenatal development and postnatal growth of eye, heart, kidney, skin, and other tissues. Expression of BMP-13 has been found in the hypertrophic chondrocytes of ossifying long bone centers. Recombinant human BMP-13/CDMP-2 is a 27 kDa homodimeric disulfide-linked protein consisting of two 120 amino acids polypeptide chains.

Postać fizyczna

Sterile filtered and Lyophilized without additives.

Rekonstytucja

Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.

Reconstitute to 0.1-1.0 mg/mL in water containing BSA (50 μg BSA per 1 μg of protein).

This page may contain text that has been machine translated.